Artificial Intelligence Can Combat Deepfakes, Cybercrimes and Snooping
University of Florida researcher Damon Woodard is using artificial intelligence methods to develop algorithms that can detect deepfakes — images, text, video and audio that purports to be real but isn’t. These algorithms, Woodard says, are better at detecting deepfakes than humans.
FDA Includes UF Researcher As Advisory Board Considers Gene Therapy Risks
FDA's Cellular, Tissue, and Gene Therapies Advisory Committee experts prepare for a two-day meeting to talk about high-dose that gene therapy developers and investigators are allowed to give patients in each trial.
Axogen RECON(SM) Clinical Study Completes Subject Follow-Up
UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that the RECON Clinical Study supporting its Biologics License Application (BLA) for Avance Nerve Graft has completed follow-up of study subjects.
UF Health Neurosurgeon Awarded $38 Million Grant To Lead National Stroke Prevention Trial
The National Institutes of Health awarded a $38 million, five-year grant to Brian Hoh, M.D., M.B.A., the University of Florida’s chair of neurosurgery, to test two new prospective treatments for symptomatic intracranial arterial stenosis, a leading cause of ischemic stroke worldwide.
Vital Signs: Leveraging Data for Better Health Outcomes
UF's Azra Bihorac says one of the most important collaborations for doctors and nurses in the future will be with the computer at a patient’s bedside.
Computing Power and Data Drive Artificial Intelligence Advances
Although data has been called the new oil, a precious resource, finding the relevant in the midst of the irrelevant is a task too big for mere mortals. It takes supercomputing, says University of Florida research computing director Erik Deumens, to turn data into knowledge.
Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice With Intramuscular and Intranasal Adjuvants
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator and licensed by the company from the National Institutes of Health (NIH) generates neutralizing antibodies in mice after immunization against SARS-CoV-2, when administered with several novel intramuscular (IM) and intranasal (IN) adjuvants.
CFO of Life Science Startup Axogen Shares How Firm Navigated Pandemic’s Health Care Disruptions
UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a life science company that is developing products for nerve repair, is ramping up hiring for scientists and engineers after navigating through the negative disruptions from the Covid-19 pandemic.
Two-Year Backlog in Biologicals Manufacturing Hinders Medical R&D, Development of New Therapies for COVID-19
One area where COVID-19 has had a substantial impact is the development and manufacturing of medicines, medical devices, and pharmaceutical products. The CDMO industry is showing enormous growth and is projected to become a $315 billion industry by 2026. However, the demand for products skyrocketed so quickly that supply has not been able to keep pace. According to Dr. Ian White, president and CSO of Neobiosis, a UF Innovate | Sid Martin Biotech resident company that focuses on the science of regenerative medicine, demand has caused a two-year backlog of desperately needed cellular and acellular products for use in research and clinical trials directed at treating the COVID-19 virus and its complications (AKA Post-COVID Syndrome).
UF Innovate | Incubation Services Resident Signum Biosciences Launches Epicutis, a Professional Luxury Medical-Grade Skincare Line
UF Innovate | Sid Martin Biotech resident Signum Biosciences, a biopharma company with 20 years of topical drug development and skincare ingredient expertise, announced the launch of Epicutis, a new professional, medical-grade luxury skincare line.
